Oral contraceptives cost effective for endometriosis-related pain

This economic evaluation by Sydenstricker Grand and colleagues assesses the cost-effectiveness of oral contraceptives compared to no hormonal treatment for managing pain associated with endometriosis. The study utilized an economic model to compare healthcare costs and outcomes, determining that providing oral contraceptives is a financially viable strategy relative to withholding hormonal therapy. The authors conclude that oral contraceptives represent a cost-effective intervention for alleviating endometriosis-related pain within the context of the analyzed healthcare system. This paper is centrally about endometriosis — specifically evaluating the economic value of oral contraceptive therapy for managing its associated chronic pelvic pain.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works